drugset / Trial / NCT02426736

Effect of Dexamethasone Dose and Route on Duration of Interscalene Block After Outpatient Shoulder Surgery

NCT02426736 ↗

Phase 4 Completed 280 enrolled University of Manitoba
RandomizedFactorialQuadruple-blindTreatment

Summary

In this factorial design study, 280 participants having outpatient, arthroscopic shoulder surgery will be randomized into 4 equal sized groups. All participants will receive a standardized interscalene brachial plexus block and 4mg or 8mg of dexamethasone given by the intravenous or perineural (by the nerve with the nerve block) route just prior to their surgery. The purpose of this study is to determine which dose and route of dexamethasone provides the longest duration of pain control and the fewest side effects after surgery. The investigators hypothesize that giving dexamethasone by the perineural route, and by higher doses, will result in the longer durations of pain control, without increased side effects.

Timeline

Start
2015-06-25
Primary completion
2016-07-12
Completion
2017-01-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 4 mg Intravenous
Comparator Dexamethasone Small molecule 8 mg Intravenous
Comparator Bupivacaine Other / unclassified 0.5 % —
Comparator Bupivacaine Other / unclassified 30 ml —

Indications

No indication recorded.